Preoperative Vascular Endothelial Growth Factor Levels as a Prognostic Marker for Stage II or III Colorectal Cancer Patients

Cancer Growth and Metastasis
doi 10.4137/cgm.s7113
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Preoperative Serum Placenta Growth Factor Level as a New Marker for Stage II or III Colorectal Cancer Patients

Turkish Journal of Gastroenterology
Gastroenterology
2012English

Endoglin (CD105) and Vascular Endothelial Growth Factor as Prognostic Markers in Colorectal Cancer

Modern Pathology
Forensic MedicinePathology
2003English

MicroRNA-9-5p-CDX2 Axis: A Useful Prognostic Biomarker for Patients With Stage II/III Colorectal Cancer

Cancers
Cancer ResearchOncology
2019English

Serum Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-1 Levels in Patients With Fibromyalgia Syndrome

Archives of Rheumatology
Rheumatology
2019English

Prognostic Value of Carcinoembryonic Antigen and Vascular Endothelial Growth Factor Tumor Tissue Content in Colorectal Cancer

Oncology
MedicineCancer ResearchOncology
2006English

Vascular Endothelial Growth Factor Plus Epidermal Growth Factor Receptor Dual Targeted Therapy in Metastatic Colorectal Cancer: Synergy or Antagonism?

Journal of Oncology
Oncology
2009English

Vascular Endothelial Growth Factor Gene Polymorphisms and Colorectal Cancer Risk: A Meta-Analysis

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2011English

Serum Vascular Endothelial Growth Factor‑C Levels: A Possible Diagnostic Marker for Lymph Node Metastasis in Patients With Primary Non‑small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2013English

Laparoscopic Colorectal Surgery and Vascular Endothelial Growth Factor

Surgical Endoscopy
Surgery
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy